In the leadup to Japan’s presidency of the G7 Summit in Hiroshima on May 19–21, 2023, JCIE has established the Hiroshima G7 Global Health Task Force under its Executive Committee on Global Health and Human Security to make recommendations to the Japanese government on the G7 agenda for global health.
To support this effort, JCIE/USA co-organized an in-person roundtable discussion with the National Academy of Medicine (NAM) featuring a presentation by the director of the task force, Dr. Hideaki Shiroyama (Director, IFI; Professor of Graduate School of Public Policy and Graduate Schools for Law and Politics, University of Tokyo), on the occasion of his visit to Washington DC. The event convened a group of approximately 30 leading US policymakers and experts to provide feedback to Dr. Shiroyama on the task force’s latest recommendations based on three main themes: 1) 100 Days Mission PLUS; 2) resilient, equitable, and sustainable UHC; and 3) global health architecture including sustainable financing. The discussion highlighted areas where Japan could make unique contributions to follow up on the previous presidencies of the G7 by the United Kingdom and Germany and shape the global discourse on future pandemic preparedness and response.
The task force is expected to finalize its recommendations early next year.
Welcoming Remarks
Kazuyo Kato, Executive Director, JCIE/USA
Victor J. Dzau, President, NAM
Presentation of Possible Recommendations to G7 by Director of the Hiroshima G7 Global Health Task Force
Hideaki Shiroyama, Professor, Graduate School of Public Policy and Graduate School of Law and Politics, University of Tokyo; Director, Institute for Future Initiatives, University of Tokyo
Moderated Discussion and Q&A
Moderated by Victor J. Dzau
Closing Remarks
Victor J. Dzau
Featured Speaker
HIDEAKI SHIROYAMA, Director, Institute for Future Initiatives; Professor of Graduate School of Public Policy and Graduate Schools for Law and Politics, University of Tokyo *Director of the Hiroshima G7 Global Health Task Force.
Speakers
DEUS BAZIRA, Director, Center for Global Health Practice and Impact, Georgetown University
CHRIS COLLINS, CEO and President, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
MARK DYBUL, Faculty Co-Director, Center for Global Health and Quality, and Professor, Department of Medicine Georgetown University Medical Center
VICTOR J. DZAU, President, US National Academy of Medicine
AMANDA GLASSMAN, Executive Vice President, Center for Global Development
MARY BETH GOODMAN, Coordinator for Global COVID Response and Health Security, US Department of State
CHRIS HASSELL, Senior Science Advisor and Deputy Assistant Secretary for Preparedness and Response, US Department of Health and Human Services
ANDREW HEBBELER, Principal Assistant Director for Health and Life Science, White House Office of Science and Technology Policy (OSTP)
KAZUYO KATO, Executive Director, JCIE/USA
MARK LAGON, Chief Policy Officer, Friends of the Global Fight
MARK LUCERA, Director for Countering Biological Threats & Global Health Security, National Security Council, The White House
STEVE MORRISON, Senior Vice President and Director, Global Policy Center, CSIS
STEPHANIE PSAKI, Director of Global Health Response, National Security Council, The White House
CAROLYN REYNOLDS, Co-Founder, PAN
PETER SCHMEISSNER, Director of the Europe Eurasia region, Office of Global Affairs, US Department of Health and Human Services
CECILIA MUNDACA SHAH, Director of Global Health, UN Foundation
TAMAKI TSUKADA, Deputy Chief of Mission at the Embassy of Japan in Washington
BRAD TYTEL, Deputy Director, Global Health R&D and Pandemic Preparedness and Response, Bill & Melinda Gates Foundation
Observers and Staff
ELIZABETH FINKELMAN, Senior Program Officer, NAM, USA
HAYLEY HUTCHISON, Global Health Program Officer, JCIE/USA
MORGAN KANAREK, Chief of Staff and Director of Operations, NAM, USA
HUMZAH KHAN, Research Associate, Global Health Policy Center, CSIS
HAYATO KUME, First Secretary, Embassy of Japan in Washington
MELISSA LAITNER, Special Assistant to the President, NAM
